Moreover, the utilization of a c-Myc inhibitor mitigated the proliferation of lung cancer cells induced by GATA6 silencing (Fig. 6I), concurrently inhibiting the upregulation of mRNA expression of genes associated with glucose metabolism induced by GATA6 silencing (Fig. 6J, k). Here, GATA6 is linked to lung carcinoma.